[Federal Register Volume 59, Number 219 (Tuesday, November 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-28082]


[[Page Unknown]]

[Federal Register: November 15, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 27, 1994, Norac 
Company Inc., 405 S. Motor Avenue, Azusa, California 91702, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the Schedule I controlled 
substances Tetrahydrocannabinols (7370).
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    The firm plans to manufacture medication for the treatment of AIDS 
wasting syndrome and as an antiemetic.
    Any such comments objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, DC 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than December 15, 
1994.

    Dated: November 4, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 94-28082 Filed 11-14-94; 8:45 am]
BILLING CODE 4410-09-M